🇺🇸 increased dosing interval of biological therapy in United States

increased dosing interval of biological therapy (increased dosing interval of biological therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

increased dosing interval of biological therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is increased dosing interval of biological therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for increased dosing interval of biological therapy in United States?

Rigshospitalet, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.